Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Three Factors to Assess Your Practice’s Medical Emergency Readiness

Medical emergencies aren’t frequent at a physician’s office. But they are always possible, and studies show they are not rare. Yet there is no national standard or requirement for primary care physicians relating to emergency medical preparedness. The good news is that the American Academy of Family Physicians (AAFP) offers three principal recommendations for preparing for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Medical emergencies aren’t frequent at a physician’s office. But they are always possible, and studies show they are not rare. Yet there is no national standard or requirement for primary care physicians relating to emergency medical preparedness.

The good news is that the American Academy of Family Physicians (AAFP) offers three principal recommendations for preparing for the most common medical emergencies. To create or improve your practice’s medical emergency preparedness plan:

  1. Assess your particular situation
  2. Consider your staff’s skills and training
  3. Create a procedure for managing emergencies

Understanding Potential Emergencies

According to the AAFP, the five most common emergencies at a physician’s office are asthma attacks, seizures, anaphylaxis, cardiac arrest/chest pain, and hypoglycemic episodes. Shock is also frequent, though less life-threatening. Unfortunately, studies suggest that most general practitioners’ offices are not adequately equipped or prepared to handle these potentially life-threatening situations.

Three Factors Determine Your Medical Emergency Readiness

As a best practice, doctor’s offices should be prepared for medical emergencies. Readiness requires the right training, medications and supplies at all times. Start by understanding your practice’s needs, using this AAFP guidance.

Analyze Your Circumstances

Equipment and medication for your emergency medical kit should reflect your patients’ (and their families’) characteristics and your office location. For instance, is your office’s patient population largely children (thus the need for pediatric medication dosage and child-appropriate devices)? Does your office cater to the elderly or chronically ill (where it’s more likely you’ll need to provide cardiac support)?

What is your proximity to the nearest hospital or emergency department? Offices located more than five miles from an emergency aid unit (where emergency response time more than doubles from urban areas) should be prepared to manage serious incidents for prolonged periods of time.

Rural practices should evaluate readiness for longer response times. That means being trained and prepared for advanced airway management, having sufficient quantities of emergency oxygen, and being up-to-date with trauma supplies.

Consider Your Skills

Properly trained team members can make a life-or-death difference. What is your staff’s level of training? Will additional training be required to accommodate potential emergencies? Team members must capably use equipment and administer medication properly. Can your personnel manage the most common side effects to drugs administered onsite? How a primary care office is equipped should be dependent upon the physicians’ and nurses’ skills and certifications in basic or advanced life support courses.

Prepare and Test Your Plan

Use the findings in the first two areas to create an emergency response procedural plan. Staff members should know your plan’s specific procedures. To increase staff confidence and improve performance when responding to medical emergencies, consider a “mock code” simulation to assess your plan, supply readiness, reaction times, and staff abilities. Ensure supplies are portable and easily accessible to staff.

Be Ready with Emergency Drugs and Equipment

For any plan to work, you should have easily accessible, up-to-date basic emergency drugs and equipment. Basic medications for the most common life-threatening emergencies are:

  • Epinephrine: Used to treat anaphylaxis resulting from severe allergic reactions
  • Albuterol: For an asthmatic attack
  • Diphenhydramine: Used to treat non-life-threatening allergic reactions
  • Aspirin: Administered as part of the MONA protocol when myocardial infarction is suspected.
  • Nitroglycerin: Coronary vasodilator used to provide relief from angina.
  • Glucose: Used to treat diabetes or hypoglycemic patients
  • Naloxone: Used to reverse the effects of opioids.

Be sure to replace emergency medications before their expiration dates to meet patient safety and FDA recommendations. An auto-replenishment system such as Banyan’s OnTraq program tracks the expiration dates of emergency medications and supplies in your emergency medical kit or crash cart and prompts replacement shipments prior to their expiration.

Turn to Banyan for Medical Emergency Preparedness

With planning, training and the right medications and equipment, offices can easily prepare for the emergencies they may encounter. Banyan can help. Guided by a medical advisory board which includes physicians that specialize in medical emergency management, Banyan offers practice-specific emergency medical equipment and medications to enable accurate life-saving responses. Contact us at 888-782-8548 or visit statkit.com.

Read more at statkit.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512